Rocket Pharmaceuticals Inc (RCKT)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

350 FIFTH AVENUE NEW YORK, NY 10118

Inotek Pharmaceuticals Corp produces and distributes pharmaceutical products. The Company specializes in developing molecules with novel mechanisms of action for the treatment of eye diseases. Inotek Pharmaceutical serves customers throughout the United States.

Data as of 2021-04-17 10:56:56 -0400
Market Cap2.681 Billion Shares Outstanding61.778 Million Avg 30-day Volume626.115 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-14.22 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.06258 52-week High/Low67.48 / 13.7 Next Earnings Date2021-04-29 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from RCKT instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 7 2 250.0% 4 (0.24%) 1 (0.06%) 300.0%
Funds Holding: 174 125 39.2% 67 (4.03%) 40 (2.49%) 67.5%
13F shares: 62.103 Million 55.075 Million 12.76% 36.439 Million 30.339 Million 20.11%
% Ownership 99.7121 60.8572 54.9291 10.79%
New Positions: 59 19 210.53% 30 5 500.0%
Increased Positions 50 41 21.95% 16 8 100.0%
Closed Positions 9 12 -25.0% 3 6 -50.0%
Reduced Positions 48 43 11.63% 16 19 -15.79%
Total Calls 126.431 Thousand 51.4 Thousand 145.97% 20.8 Thousand 12.8 Thousand 62.5%
Total Puts 199.963 Thousand 4.3 Thousand 4550.3% 74.6 Thousand
PUT/CALL Ratio 1.58 0.08 1875.0% 3.59 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding RCKT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RCKT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

169.8 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SHAH GAURAV CEO

901,877 2021-03-31 4

RTW INVESTMENTS, LP

WONG RODERICK

YALAMANCHI NAVEEN

  • Director
  • 10% Owner
16,185,119 2021-03-24 2

PATEL KINNARI CHIEF OPERATING OFFICER

290,551 2021-03-24 5

SCHWARTZ JONATHAN DAVID CHIEF MEDICAL OFFICER

0 2021-02-04 2

MILITELLO JOHN SEE REMARKS

0 2021-02-04 2

GARCIA-PARADA CARLOS CHIEF FINANCIAL OFFICER

0 2021-01-04 2

GRANADILLO PEDRO P

0 2020-12-31 2

YALAMANCHI NAVEEN

82,391 2020-12-31 2

SOUTHWELL DAVID P

0 2020-06-16 1

BOESS CARSTEN

0 2020-06-16 1

MAKKER GOTHAM

0 2020-06-16 1

WONG RODERICK

0 2020-06-16 1

BJORK ELISABETH

0 2020-06-16 1

ALAM KAMRAN SVP - FINANCE & PFO

  • Officer
0 2020-02-06 0

BATCHELDER BRIAN SEE REMARKS

  • Officer
0 2018-01-04 0

RITTER DALE VICE PRESIDENT, FINANCE

  • Officer
19,827 2017-09-14 0

HOWES PAUL G

  • Director
0 2017-06-20 0

SPIVEY RICHARD N.

  • Director
0 2017-06-20 0

PHILLIPS GARY M.

  • Director
0 2017-06-20 0

CARROLL J MARTIN

  • Director
0 2017-06-20 0

MACHADO PATRICK

  • Director
0 2017-06-20 0

BARBERICH TIMOTHY J

  • Director
0 2017-06-20 0

BAUMGARTNER RUDOLF A SEE REMARKS

  • Officer
0 2017-01-23 0

DEVON PARK BIOVENTURES LP

DEVON PARK ASSOCIATES, L.P.

DEVON PARK ASSOCIATES, LLC

  • 10% Owner
No longer subject to file 2017-01-04 0

MCVICAR WILLIAM K. SEE REMARKS

  • Officer
0 2016-03-22 0

RHO VENTURES IV HOLDINGS LLC

RHO VENTURES IV-A, L.P.

  • 10% Owner
No longer subject to file 2015-11-16 0

DEVON PARK ASSOCIATES, L.P.

DEVON PARK ASSOCIATES, LLC

KANTESARIA DEVANG

  • 10% Owner
3,253,566 2015-07-14 0

PEIMER ISAI

  • Director
0 2015-06-24 0

VOGELBAUM MARTIN

  • Director
0 2015-06-24 0

KARABELAS ARGERIS N

  • Director
  • 10% Owner
0 2015-06-24 0

CARE CAPITAL II LLC

CARE CAPITAL INVESTMENTS II LP

CARE CAPITAL OFFSHORE INVESTMENTS II LP

CARE CAPITAL III LLC

CARE CAPITAL INVESTMENTS III L.P.

CARE CAPITAL OFFSHORE INVESTMENTS III LP

  • 10% Owner
0 2015-06-24 0

HAREL ITTAI

  • Director
0 2015-06-24 0

MEDIMMUNE VENTURES, INC.

  • 10% Owner
1,917,906 2015-02-23 0

KANTESARIA DEVANG

  • 10% Owner
3,243,709 2015-02-23 0

RHO VENTURES IV QP LP

RHO VENTURES IV GMBH & CO BETEILIGUNGS KG

RHO VENTURES IV HOLDINGS LLC

RHO VENTURES IV LP

RHO VENTURES IV-A, L.P.

RHO MANAGEMENT VENTURES IV LLC

RHO CAPITAL PARTNERS VERWALTUNGS GMBH

KAIROUZ HABIB

RUCH JOSHUA

LESCHLY MARK

  • 10% Owner
2,870,584 2015-02-23 0

PITANGO VENTURE CAPITAL PRINCIPALS FUND IV, L.P.

PITANGO VENTURE CAPITAL FUND IV, L.P.

PITANGO V.C. FUND IV, L.P.

PITANGO G.C. CAPITAL HOLDINGS LTD.

  • 10% Owner
1,292,584 2015-02-23 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SHAH GAURAV CEO

2021-04-01 21:09:30 -0400 2021-04-01 F 7,475 $47.21 d 495,639 direct yes -8.0815 -12.1758 0.0 1 -15.5198 5

SHAH GAURAV CEO

2021-04-01 21:09:30 -0400 2021-04-01 F 8,872 $46.45 d 503,114 direct yes -8.0815 -12.1758 0.0 1 -15.5198 5

SHAH GAURAV CEO

2021-04-01 21:09:30 -0400 2021-04-01 F 5,919 $45.21 d 511,986 direct yes -8.0815 -12.1758 0.0 1 -15.5198 5

SHAH GAURAV CEO

2021-04-01 21:09:30 -0400 2021-03-31 F 7,493 $45.94 d 517,905 direct yes -8.0815 -12.1758 0.0 1 -15.5198 5

SHAH GAURAV CEO

2021-04-01 21:08:38 -0400 2021-03-31 F 61,350 $44.24 d 548,401 direct yes -8.0815 -12.1758 0.0 1 -15.5198 5

SHAH GAURAV CEO

2021-04-01 21:08:38 -0400 2021-03-31 M 75,880 d 0 direct

SHAH GAURAV CEO

2021-04-01 21:08:38 -0400 2021-03-31 F 3,000 $45.59 d 609,751 direct -8.0815 -12.1758 0.0 1 -15.5198 5

SHAH GAURAV CEO

2021-04-01 21:08:38 -0400 2021-03-31 F 23,003 $45.06 d 525,398 direct yes -8.0815 -12.1758 0.0 1 -15.5198 5

SHAH GAURAV CEO

2021-04-01 21:08:38 -0400 2021-03-31 M 75,880 $1.69 a 612,751 direct -8.0815 -12.1758 0.0 1 -15.5198 5

SHAH GAURAV CEO

2021-04-01 21:08:38 -0400 2021-03-30 F 8,505 $44.34 d 536,871 direct yes -8.0815 -12.1758 0.0 1 -15.5198 5

SHAH GAURAV CEO

2021-04-01 21:08:38 -0400 2021-03-30 F 19,984 $41.80 d 614,092 direct yes -8.0815 -12.1758 0.0 1 -15.5198 5

SHAH GAURAV CEO

2021-04-01 21:08:38 -0400 2021-03-30 F 48,732 $43.86 d 545,376 direct yes -8.0815 -12.1758 0.0 1 -15.5198 5

SHAH GAURAV CEO

2021-04-01 21:08:38 -0400 2021-03-30 F 8,667 $42.80 d 594,108 direct yes -8.0815 -12.1758 0.0 1 -15.5198 5

PATEL KINNARI CHIEF OPERATING OFFICER

2021-03-26 18:17:44 -0400 2021-03-24 M 55,869 $1.21 a 150,846 direct -1.6341 -2.6782 5.8783 5 -2.6782 6

PATEL KINNARI CHIEF OPERATING OFFICER

2021-03-26 18:17:44 -0400 2021-03-24 M 55,869 d 0 direct

RTW INVESTMENTS, LP - Director - > 10% Owner see footnote

WONG RODERICK - Director - > 10% Owner see footnote

YALAMANCHI NAVEEN - Director see footnote

2021-03-29 20:01:18 -0400 2021-03-24 J 1,344,925 d 16,185,119 indirect 2.3766 -3.1841 7.6373 4 -3.1841 6

PATEL KINNARI CHIEF OPERATING OFFICER

2021-03-26 18:17:44 -0400 2021-03-24 M 38,093 $1.69 a 188,939 direct -1.6341 -2.6782 5.8783 5 -2.6782 6

PATEL KINNARI CHIEF OPERATING OFFICER

2021-03-26 18:17:44 -0400 2021-03-24 M 38,093 d 0 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ROCKET PHARMACEUTICALS INC RCKT 2021-04-20 22:15:03 UTC -0.19 0.25 450000
ROCKET PHARMACEUTICALS INC RCKT 2021-04-20 21:45:03 UTC -0.19 0.25 450000
ROCKET PHARMACEUTICALS INC RCKT 2021-04-20 21:15:02 UTC -0.19 0.25 450000
ROCKET PHARMACEUTICALS INC RCKT 2021-04-20 20:45:03 UTC -0.19 0.25 450000
ROCKET PHARMACEUTICALS INC RCKT 2021-04-20 20:15:04 UTC -0.19 0.25 450000
ROCKET PHARMACEUTICALS INC RCKT 2021-04-20 19:45:03 UTC -0.19 0.25 450000
ROCKET PHARMACEUTICALS INC RCKT 2021-04-20 19:15:03 UTC -0.19 0.25 450000
ROCKET PHARMACEUTICALS INC RCKT 2021-04-20 18:45:03 UTC -0.19 0.25 450000
ROCKET PHARMACEUTICALS INC RCKT 2021-04-20 18:15:03 UTC -0.19 0.25 450000
ROCKET PHARMACEUTICALS INC RCKT 2021-04-20 17:45:02 UTC -0.19 0.25 450000
ROCKET PHARMACEUTICALS INC RCKT 2021-04-20 17:15:02 UTC -0.19 0.25 450000
ROCKET PHARMACEUTICALS INC RCKT 2021-04-20 16:45:03 UTC -0.19 0.25 450000
ROCKET PHARMACEUTICALS INC RCKT 2021-04-20 16:15:03 UTC -0.19 0.25 450000
ROCKET PHARMACEUTICALS INC RCKT 2021-04-20 15:45:03 UTC -0.19 0.25 450000
ROCKET PHARMACEUTICALS INC RCKT 2021-04-20 15:15:02 UTC -0.19 0.25 450000
ROCKET PHARMACEUTICALS INC RCKT 2021-04-20 14:45:03 UTC -0.1918 0.2518 450000
ROCKET PHARMACEUTICALS INC RCKT 2021-04-20 14:15:03 UTC -0.1918 0.2518 450000
ROCKET PHARMACEUTICALS INC RCKT 2021-04-20 13:45:03 UTC -0.1918 0.2518 450000
ROCKET PHARMACEUTICALS INC RCKT 2021-04-20 13:15:04 UTC -0.1918 0.2518 450000
ROCKET PHARMACEUTICALS INC RCKT 2021-04-20 12:45:03 UTC -0.1918 0.2518 450000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Trust for Professional Managers- Convergence Long/Short Equity Fund RCKT -1298.0 shares, $-40186.08 2020-11-30 N-PORT
FundVantage Trust- Gotham Enhanced Index Plus Fund RCKT -12.0 shares, $-167.4 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund RCKT -21.0 shares, $-292.95 2020-03-31 N-PORT
VANGUARD MONTGOMERY FUNDS- VANGUARD MARKET NEUTRAL FUND RCKT -5324.0 shares, $-291968.16 2020-12-31 N-PORT

Elevate your investments